These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38294129)

  • 1. Protective effect of alpha-lipoic acid and epalrestat on oxaliplatin-induced peripheral neuropathy in zebrafish.
    Lee DW; Park HC; Kim DH
    Muscle Nerve; 2024 Apr; 69(4):498-503. PubMed ID: 38294129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy.
    Wang X; Lin H; Xu S; Jin Y; Zhang R
    Drug Des Devel Ther; 2018; 12():2827-2840. PubMed ID: 30233145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical efficacy of epalrestat combined with α-lipoic acid in diabetic peripheral neuropathy: Protocol for a systematic review and meta-analysis.
    Wang X; Lin H; Xu S; Jin Y; Zhang R
    Medicine (Baltimore); 2018 Feb; 97(6):e9828. PubMed ID: 29419686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoic Acid Combined with Epalrestat versus Lipoic Acid in Treating Diabetic Peripheral Neuropathy:A Meta-analysis.
    Wang XT; Lin HX; Xu SA; Lu YK
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):656-664. PubMed ID: 29125108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of epalrestat plus α-lipoic acid combination therapy
    Zhao M; Chen JY; Chu YD; Zhu YB; Luo L; Bu SZ
    Neural Regen Res; 2018 Jun; 13(6):1087-1095. PubMed ID: 29926837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of peripheral nerve protection between insulin-based glucose control and alpha lipoic acid (ALA) in the streptozotocin (STZ)-induced diabetic rat.
    Lee KA; Lee NY; Park TS; Jin HY
    Endocrine; 2018 Jul; 61(1):58-67. PubMed ID: 29736880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial.
    Guo Y; Jones D; Palmer JL; Forman A; Dakhil SR; Velasco MR; Weiss M; Gilman P; Mills GM; Noga SJ; Eng C; Overman MJ; Fisch MJ
    Support Care Cancer; 2014 May; 22(5):1223-31. PubMed ID: 24362907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sensory tests and neuronal quantity of peripheral nerves between streptozotocin (STZ)-induced diabetic rats and paclitaxel (PAC)-treated rats.
    Jin HY; Lee NY; Ko HA; Lee KA; Park TS
    Somatosens Mot Res; 2016; 33(3-4):186-195. PubMed ID: 27756190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on symptoms of diabetic peripheral neuropathy.
    Han Y; Wang M; Shen J; Zhang Z; Zhao M; Huang J; Chen Y; Chen Z; Hu Y; Wang Y
    Minerva Endocrinol; 2018 Mar; 43(1):11-18. PubMed ID: 27901334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Examination of questionnaires regarding diabetic peripheral neuropathy in epalrestat-treated patients and their usefulness in the treatment of the patients during the treatment course].
    Ito A; Ishii-Nozawa R; Ibuki C; Atarashi H; Kataoka H; Takeuchi K
    Yakugaku Zasshi; 2009 Oct; 129(10):1239-47. PubMed ID: 19797880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.
    Alberti P; Canta A; Chiorazzi A; Fumagalli G; Meregalli C; Monza L; Pozzi E; Ballarini E; Rodriguez-Menendez V; Oggioni N; Sancini G; Marmiroli P; Cavaletti G
    Neuropharmacology; 2020 Mar; 164():107905. PubMed ID: 31811874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of drug transporters contributing to oxaliplatin-induced peripheral neuropathy.
    Fujita S; Hirota T; Sakiyama R; Baba M; Ieiri I
    J Neurochem; 2019 Feb; 148(3):373-385. PubMed ID: 30295925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Curative effect of alpha-lipoic acid on peripheral neuropathy in type 2 diabetes: a clinical study].
    Liu F; Zhang Y; Yang M; Liu B; Shen YD; Jia WP; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2706-9. PubMed ID: 18167250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.
    Joseph EK; Chen X; Bogen O; Levine JD
    J Pain; 2008 May; 9(5):463-72. PubMed ID: 18359667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy.
    Melli G; Taiana M; Camozzi F; Triolo D; Podini P; Quattrini A; Taroni F; Lauria G
    Exp Neurol; 2008 Dec; 214(2):276-84. PubMed ID: 18809400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Bortezomib-Related Peripheral Neuropathy With Docosahexaenoic Acid and α-Lipoic Acid in Patients With Multiple Myeloma: Preliminary Data.
    Maschio M; Zarabla A; Maialetti A; Marchesi F; Giannarelli D; Gumenyuk S; Pisani F; Renzi D; Galiè E; Mengarelli A
    Integr Cancer Ther; 2018 Dec; 17(4):1115-1124. PubMed ID: 30295079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidants Improve Oxaliplatin-Induced Peripheral Neuropathy in Tumor-Bearing Mice Model: Role of Spinal Cord Oxidative Stress and Inflammation.
    Agnes JP; Santos VWD; das Neves RN; Gonçalves RM; Delgobo M; Girardi CS; Lückemeyer DD; Ferreira MA; Macedo-Júnior SJ; Lopes SC; Spiller F; Gelain DP; Moreira JCF; Prediger RD; Ferreira J; Zanotto-Filho A
    J Pain; 2021 Aug; 22(8):996-1013. PubMed ID: 33774154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth.
    Cerles O; Gonçalves TC; Chouzenoux S; Benoit E; Schmitt A; Bennett Saidu NE; Kavian N; Chéreau C; Gobeaux C; Weill B; Coriat R; Nicco C; Batteux F
    Acta Neuropathol Commun; 2019 Jan; 7(1):9. PubMed ID: 30657060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of phosphatidylcholine on oxaliplatin-induced neuropathy in rats.
    Kim ST; Chung YH; Lee HS; Chung SJ; Lee JH; Sohn UD; Shin YK; Park ES; Kim HC; Bang JS; Jeong JH
    Life Sci; 2015 Jun; 130():81-7. PubMed ID: 25817232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of epalrestat mediated through oxidative stress markers, cytokines and TAU protein levels in diabetic rats.
    Jaiswal S; Mishra S; Torgal SS; Shengule S
    Life Sci; 2018 Aug; 207():364-371. PubMed ID: 29936149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.